The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and Research (CDER) in veteran biotech executive George Tidmarsh, M.D., Ph.D.

The FDA just approved Gardenia (genipin) blue, a natural food dye, for certain foods and drinks. They’re also trying to expedite the ban of Red No. 3 before the January 15, 2027, deadline. Some ...

Tidmarsh appointed to lead FDA's Center for Drug Evaluation and Research Biotech veteran led development of 7 FDA-approved drugs He is currently adjunct faculty of pediatrics and neonatology at ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing seven FDA-approved drugs.

Michelle Pfeiffer slammed new food tech brand Apeel Sciences via her Instagram Stories on Thursday after the brand became FDA-approved for use on organic produce.

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.

Patients with neuro conditions are asked to consult with their neurologist, above all else, before seeking out therapeutic solutions not previously approved by the FDA, according to a position ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes treatment of drug refractory, symptomatic persistent atrial fibrillation ...

The FDA first approved lenacapavir (as Sunlenca) in 2022 in combination with other antiretrovirals, as a twice-yearly option for the treatment of HIV-1 infection in heavily treatment-experienced ...

(Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and longtime Stanford University professor, as the director of the ...

For the second time in under 3 weeks, the FDA has approved a treatment for the inherited genetic disorder characterized by recurrent episodes of severe swelling.